Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray

Barchart · 2d ago


Bagsværd, Denmark, 5 August 2026 — The District Court of The Hague has granted Novo Nordisk a preliminary injunction against Ceban Ziekenhuisfarmacie B.V., ordering the company to immediately stop selling a compounded semaglutide nasal spray that infringes Novo Nordisk's intellectual property. The ruling protects patients from unapproved formulations of semaglutide and reinforces the regulatory framework that ensures medicines meet established standards for quality, safety and efficacy.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.